Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedNov 15, 2024
DataAggregated Company Financials
Companies9
- 7D1.6%
- 3M1.2%
- 1Y47.6%
- YTD34.6%
In the last week, the Biotech industry is up 1.6%, with Biocon up 2.4%. In the last 12 months, the industry was up 48%. As for the next few years, earnings are expected to grow by 6.0% per annum.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 15 Nov 2024 | ₹448.7b | ₹159.0b | ₹14.3b | 39.3x | 31.3x | 2.8x |
| Sun, 13 Oct 2024 | ₹462.7b | ₹157.7b | ₹15.7b | 33.3x | 29.4x | 2.9x |
| Tue, 10 Sep 2024 | ₹498.8b | ₹157.7b | ₹15.7b | 36.1x | 31.7x | 3.2x |
| Thu, 08 Aug 2024 | ₹454.2b | ₹157.3b | ₹10.4b | 40.6x | 43.9x | 2.9x |
| Sat, 06 Jul 2024 | ₹481.5b | ₹157.4b | ₹10.4b | 46.2x | 46.5x | 3.1x |
| Mon, 03 Jun 2024 | ₹399.4b | ₹157.3b | ₹10.3b | 43.7x | 38.9x | 2.5x |
| Wed, 01 May 2024 | ₹386.9b | ₹155.4b | ₹12.0b | 37x | 32.2x | 2.5x |
| Fri, 29 Mar 2024 | ₹341.4b | ₹155.4b | ₹12.0b | 31.9x | 28.4x | 2.2x |
| Sun, 25 Feb 2024 | ₹356.6b | ₹155.4b | ₹12.0b | 40.8x | 29.7x | 2.3x |
| Tue, 23 Jan 2024 | ₹358.8b | ₹145.0b | ₹5.3b | 57.7x | 68.3x | 2.5x |
| Thu, 21 Dec 2023 | ₹319.5b | ₹145.0b | ₹5.3b | 53.1x | 60.8x | 2.2x |
| Sat, 18 Nov 2023 | ₹307.4b | ₹145.0b | ₹5.3b | 53.3x | 58.5x | 2.1x |
| Mon, 16 Oct 2023 | ₹335.5b | ₹133.7b | ₹4.8b | 34.5x | 70.6x | 2.5x |
| Wed, 13 Sep 2023 | ₹347.9b | ₹133.8b | ₹4.8b | 29.2x | 72.8x | 2.6x |
| Fri, 11 Aug 2023 | ₹340.9b | ₹120.8b | ₹4.5b | 40.6x | 75.1x | 2.8x |
| Sun, 09 Jul 2023 | ₹330.9b | ₹120.4b | ₹4.5b | 41.3x | 73.4x | 2.7x |
| Tue, 06 Jun 2023 | ₹314.7b | ₹120.8b | ₹4.5b | 40.2x | 70x | 2.6x |
| Thu, 04 May 2023 | ₹315.8b | ₹106.7b | ₹16.2b | 29.2x | 19.4x | 3x |
| Sat, 01 Apr 2023 | ₹273.4b | ₹106.6b | ₹16.4b | 21.3x | 16.7x | 2.6x |
| Mon, 27 Feb 2023 | ₹301.1b | ₹106.3b | ₹16.3b | 35.2x | 18.5x | 2.8x |
| Wed, 25 Jan 2023 | ₹327.8b | ₹99.2b | ₹18.0b | 31.4x | 18.3x | 3.3x |
| Fri, 23 Dec 2022 | ₹355.7b | ₹99.2b | ₹18.0b | 34x | 19.8x | 3.6x |
| Sun, 20 Nov 2022 | ₹377.0b | ₹99.2b | ₹17.9b | 35.1x | 21x | 3.8x |
| Tue, 18 Oct 2022 | ₹347.7b | ₹95.5b | ₹18.1b | 29.9x | 19.2x | 3.6x |
| Thu, 15 Sep 2022 | ₹401.7b | ₹95.5b | ₹18.1b | 34.3x | 22.2x | 4.2x |
| Sat, 13 Aug 2022 | ₹409.9b | ₹95.5b | ₹18.2b | 33.8x | 22.5x | 4.3x |
| Mon, 11 Jul 2022 | ₹422.9b | ₹92.1b | ₹17.7b | 32.1x | 24x | 4.6x |
| Wed, 08 Jun 2022 | ₹416.8b | ₹92.0b | ₹17.5b | 32x | 23.8x | 4.5x |
| Fri, 06 May 2022 | ₹463.2b | ₹85.4b | ₹6.9b | 54.2x | 66.9x | 5.4x |
| Sun, 03 Apr 2022 | ₹441.4b | ₹79.4b | ₹7.0b | 57x | 62.7x | 5.6x |
| Tue, 01 Mar 2022 | ₹446.4b | ₹79.4b | ₹7.0b | 53.4x | 63.4x | 5.6x |
| Thu, 27 Jan 2022 | ₹479.3b | ₹79.4b | ₹7.1b | 62.2x | 67.7x | 6x |
| Sat, 25 Dec 2021 | ₹460.4b | ₹76.2b | ₹6.9b | 63.7x | 66.8x | 6x |
| Mon, 22 Nov 2021 | ₹470.8b | ₹76.2b | ₹6.9b | 55x | 68.3x | 6.2x |
Price to Earnings Ratio
68.3x
Current Industry PE
- Investors are pessimistic on the Indian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 31.3x which is lower than its 3-year average PE of 42.8x.
- The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 28% per year over the last three years.
- Revenues for these companies have grown 28% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -4.32% | |
| Healthcare | -3.61% | |
| Biotech | 1.56% | |
| Biotech | 1.56% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹335.80 | 4.5% +₹17.4b | 44.3% | PE27.9x | |
| NIRMAN Nirman Agri Genetics | ₹372.85 | 7.8% +₹160.3m | 67.2% | PE16.4x | |
| 526139 Transgene Biotek | ₹6.81 | 4.0% +₹19.7m | -5.2% | PS280x | |
| PANACEABIO Panacea Biotec | ₹357.70 | 0.06% +₹12.3m | 135.1% | PS4x | |
| 514336 Genesis IBRC India | ₹16.64 | 5.0% +₹10.3m | 70.8% | PB4.4x |